A New Era in Therapeutic Innovation The pharmaceutical landscape is shifting rapidly, and at the heart of this transformation is the rise of oligonucleotide therapeutics. According to a recent report by MarketsandMarkets, the global oligonucleotide CDMO market is projected to reach a valuation of $11.14 billion by 2031, growing at a significant CAGR during the…